The Biostatistics and Bioinformatics Core for the University of Texas M. D. Anderson Cancer Center (UTMDACC) Melanoma SPORE will serve multiple needs for the planning and conduct of the SPORE's translational reseal-ch. Based on a strong track record for providing biostatistical support for translational research, the Core will be,a comprehensive, muiti^lateral respurce for designing clinical and basic science experiments, performing statistical analyses, developing innovative statistical methodology, and publishing the research results generated from this Melanoma SPORE. For this proposed competitive renewal, we plan to continue and to expand the role of the Core in supporting the UTMDACC Melanoma SPORE. We will incorporate sound experimental design principles within each project that will increase the clarity,and enhance interpretability of study results. Each project will be provided with tailored analyses, accompanied by novel statistical development as necessary;to reveal apparent and hidden relationships among data.. The Core will collaborate with all project investigators to facilitate the timely publication of Melanoma SPORE research. The main objectives of the Biostatistics and Bioinformatics Core are: 1. To provide guidance for the statistical design and sample size and power calculations for each project. 2. To provide all statistical data analysis including descriptive statistical analysis, hypothesis testing, estimation, and modeling bf prospectively generated data., 3. To ascertain that conclusions drawn, from a|l projects are based on well-designed experiments and appropriate interpretation of results. 4. To develop and adapt innovative statistical methods pertinent to translational melanoma studies. 5. To generate statistical reports for all projects. 6. To collaborate and assist all project investigators in the publication of scientific results.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA093459-09
Application #
8541580
Study Section
Special Emphasis Panel (ZCA1-RPRB-M)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
9
Fiscal Year
2013
Total Cost
$219,180
Indirect Cost
$78,463
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Chacon, Jessica Ann; Sarnaik, Amod A; Chen, Jie Qing et al. (2015) Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy. Clin Cancer Res 21:611-21
Fang, Shenying; Wang, Yuling; Chun, Yun Shin et al. (2015) The relationship between blood IL-12p40 level and melanoma progression. Int J Cancer 136:1874-80
Siroy, Alan E; Boland, Genevieve M; Milton, DenĂ¡i R et al. (2015) Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol 135:508-15
Chattopadhyay, Chandrani; Grimm, Elizabeth A; Woodman, Scott E (2014) Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migration. PLoS One 9:e83957
Sim, Geok Choo; Chacon, Jessica; Haymaker, Cara et al. (2014) Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development. BioDrugs 28:421-37
Rees, Elliott; Walters, James T R; Georgieva, Lyudmila et al. (2014) Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry 204:108-14
Lopez-Rivera, Esther; Jayaraman, Padmini; Parikh, Falguni et al. (2014) Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2. Cancer Res 74:1067-78
Boraska, V; Franklin, C S; Floyd, J A B et al. (2014) A genome-wide association study of anorexia nervosa. Mol Psychiatry 19:1085-94
Singh, Manisha; Khong, Hiep; Dai, Zhimin et al. (2014) Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation. J Immunol 193:4722-31
Wang, Yun; Hu, Shougang; Gabisi Jr, Abdul M et al. (2014) Developing an irreversible inhibitor of human DDAH-1, an enzyme upregulated in melanoma. ChemMedChem 9:792-7

Showing the most recent 10 out of 144 publications